Related Articles
Matrix metalloproteinase‑2 and ‑9 and tissue inhibitor of metalloproteinase‑1 and ‑2 in sera and urine of patients with renal carcinoma
Ulinastatin reduces urinary sepsis‑related inflammation by upregulating IL‑10 and downregulating TNF‑α levels
Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Role of hyaluronan and hyaluronan synthase in endometrial cancer
Clinical observation of ulinastatin combined with CRRT in the treatment of early cardiopulmonary resuscitation